Usefulness of microalbuminuria in patients with the metabolic syndrome to predict subclinical atherosclerosis and cardiovascular disease outcomes.
Afonso L, Hari P, Kondur A, Veeranna V, Manickam P, Simegn M, Jacob S, Ference B. Usefulness of microalbuminuria in patients with the metabolic syndrome to predict subclinical atherosclerosis and cardiovascular disease outcomes. Am J Cardiol. 2010 Oct 01; 106(7):976-83.